Quality of life during potentially curative treatment for locally advanced oesophageal cancer - PubMed (original) (raw)
Comparative Study
. 2007 Nov;94(11):1369-76.
doi: 10.1002/bjs.5888.
Affiliations
- PMID: 17665422
- DOI: 10.1002/bjs.5888
Comparative Study
Quality of life during potentially curative treatment for locally advanced oesophageal cancer
K N L Avery et al. Br J Surg. 2007 Nov.
Abstract
Background: Combination chemoradiotherapy with or without surgery are internationally applied alternative strategies for potential cure of oesophageal cancer. This study compared health-related quality of life (HRQL) between patients selected for chemoradiation and those who had combination treatment including oesophagectomy.
Methods: Patients with stage II or III oesophageal cancer completed HRQL assessments at baseline, at the worst expected HRQL time point and at expected recovery. HRQL was compared between groups using linear regression, adjusting for age, sex, performance status, tumour stage and type, and baseline HRQL.
Results: Some 132 patients began treatment, of whom 51 had chemoradiotherapy and 81 combination treatment including surgery. Patients selected for chemoradiotherapy were older, more likely to have squamous cell cancer and reported poorer HRQL than those selected for surgery. At the worst expected time point after treatment, both groups reported multiple symptoms and poor function, but surgery was associated with a greater reduction in HRQL from baseline than chemoradiotherapy. Recovery of HRQL was achieved within 6 months after chemoradiotherapy, but complete recovery had not occurred 6 months after surgery and there was persistent significant deterioration in some aspects.
Conclusion: The negative treatment-related impact of chemoradiation on short-term HRQL is less than that experienced with combination treatment including surgery. Patients preferring early recovery should consider definitive chemoradiation.
Copyright (c) 2007 British Journal of Surgery Society Ltd.
Similar articles
- Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma.
Blazeby JM, Sanford E, Falk SJ, Alderson D, Donovan JL. Blazeby JM, et al. Cancer. 2005 May 1;103(9):1791-9. doi: 10.1002/cncr.20980. Cancer. 2005. PMID: 15779022 - Assessing the relationships between health-related quality of life and postoperative length of hospital stay after oesophagectomy for cancer of the oesophagus and the gastro-oesophageal junction.
Nafteux P, Durnez J, Moons J, Coosemans W, Decker G, Lerut T, Van Veer H, De Leyn P. Nafteux P, et al. Eur J Cardiothorac Surg. 2013 Sep;44(3):525-33; discussion 533. doi: 10.1093/ejcts/ezt064. Epub 2013 Mar 21. Eur J Cardiothorac Surg. 2013. PMID: 23520231 - Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.
Mariette C, Piessen G, Triboulet JP. Mariette C, et al. Lancet Oncol. 2007 Jun;8(6):545-53. doi: 10.1016/S1470-2045(07)70172-9. Lancet Oncol. 2007. PMID: 17540306 Review. - [Salvage surgery: cancer of the esophagus].
Triboulet JP. Triboulet JP. Bull Cancer. 2011 Jan;98(1):73-8. doi: 10.1684/bdc.2010.1293. Bull Cancer. 2011. PMID: 21300611 Review. French.
Cited by
- Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs).
Macefield RC, Jacobs M, Korfage IJ, Nicklin J, Whistance RN, Brookes ST, Sprangers MA, Blazeby JM. Macefield RC, et al. Trials. 2014 Feb 5;15:49. doi: 10.1186/1745-6215-15-49. Trials. 2014. PMID: 24495582 Free PMC article. Review. - Ivor-Lewis oesophagogastrectomy with Roux-en-Y duodenal bypass.
Cartwright J, Forbat E, Botha A. Cartwright J, et al. Ann R Coll Surg Engl. 2016 Feb;98(2):116-20. doi: 10.1308/rcsann.2016.0009. Epub 2016 Jan 7. Ann R Coll Surg Engl. 2016. PMID: 26741669 Free PMC article. - Systematic review of health-related quality of life after esophagectomy for esophageal cancer.
Scarpa M, Valente S, Alfieri R, Cagol M, Diamantis G, Ancona E, Castoro C. Scarpa M, et al. World J Gastroenterol. 2011 Nov 14;17(42):4660-74. doi: 10.3748/wjg.v17.i42.4660. World J Gastroenterol. 2011. PMID: 22180708 Free PMC article. Review. - Evaluating the role of fluorodeoxyglucose positron emission tomography-computed tomography in multi-disciplinary team recommendations for oesophago-gastric cancer.
Blencowe NS, Whistance RN, Strong S, Hotton EJ, Ganesh S, Roach H, Callaway M, Blazeby JM. Blencowe NS, et al. Br J Cancer. 2013 Sep 17;109(6):1445-50. doi: 10.1038/bjc.2013.478. Epub 2013 Aug 20. Br J Cancer. 2013. PMID: 23963146 Free PMC article. - Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer.
Rees J, Hurt CN, Gollins S, Mukherjee S, Maughan T, Falk SJ, Staffurth J, Ray R, Bashir N, Geh JI, Cunningham D, Roy R, Bridgewater J, Griffiths G, Nixon LS, Blazeby JM, Crosby T. Rees J, et al. Br J Cancer. 2015 Aug 11;113(4):603-10. doi: 10.1038/bjc.2015.258. Epub 2015 Jul 23. Br J Cancer. 2015. PMID: 26203761 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical